The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125839762 12583976 2 F 20150101 20160915 20160722 20160919 EXP PHHY2015EC050733 NOVARTIS 43.84 YR M Y 0.00000 20160919 CN COUNTRY NOT SPECIFIED EC

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125839762 12583976 1 PS TASIGNA NILOTINIB 1 Oral 400 MG, BID 319800 MG D 22068 400 MG CAPSULE BID
125839762 12583976 2 SS TASIGNA NILOTINIB 1 Oral 200 MG, QD 319800 MG D 22068 200 MG CAPSULE QD
125839762 12583976 3 SS TASIGNA NILOTINIB 1 Oral 200 MG, Q48H 319800 MG D 22068 200 MG CAPSULE
125839762 12583976 4 SS TASIGNA NILOTINIB 1 Oral 200 MG, QD 319800 MG D 22068 200 MG CAPSULE QD
125839762 12583976 5 SS TASIGNA NILOTINIB 1 Oral 200 MG, BID 319800 MG D 22068 200 MG CAPSULE BID
125839762 12583976 6 SS TASIGNA NILOTINIB 1 Oral 400 MG, BID 319800 MG D 22068 400 MG CAPSULE BID
125839762 12583976 7 SS TASIGNA NILOTINIB 1 Oral 200 MG, TID 319800 MG D 22068 200 MG CAPSULE TID
125839762 12583976 8 SS TASIGNA NILOTINIB 1 Oral 400 MG, BID 319800 MG D 22068 400 MG CAPSULE BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125839762 12583976 1 Chronic myeloid leukaemia

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125839762 12583976 Arthralgia
125839762 12583976 Back pain
125839762 12583976 Chest pain
125839762 12583976 Headache
125839762 12583976 Hyperhidrosis
125839762 12583976 Incorrect drug administration duration
125839762 12583976 Influenza
125839762 12583976 Oropharyngeal pain
125839762 12583976 Pain
125839762 12583976 Pyrexia
125839762 12583976 Urinary tract disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125839762 12583976 1 20141030 20150708 0
125839762 12583976 2 20150709 20150807 0
125839762 12583976 3 20150909 20160211 0
125839762 12583976 4 20160212 20160512 0
125839762 12583976 5 20160513 20160608 0
125839762 12583976 6 20160609 20160707 0
125839762 12583976 7 20160708 20160807 0
125839762 12583976 8 20160808 20160910 0